Download PDF
Thromb Haemost 1966; 16(01/02): 318-330
DOI: 10.1055/s-0038-1655566
Übersichten — Reviews — Revues Générales
Schattauer GmbH

Current Blood Clotting Schemes[*]

A. J Quick
1   Marquette University, School of Medicine, Milwaukee, Wisconsin 53233
,
Professor Emeritus of Biochemistry › Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

    Permissions and Reprints

Summary

Currently, there are three schemes to explain the coagulation of blood, each representing an attempt to unravel the complex process. The lack of agreement can be attributed, first, to the experimental approaches and, secondly, to the objective. To evaluate accurately the reliability of the various methods employed in isolating clotting factors and in studying their properties would require the wisdom of Solomon. While both the cascade sequence theory and Seegers’ approach have as their main aim to study the chemistry of blood coagulation, the primary objective of the expanded classical theory is to serve diagnostically. The final goal - the correlation of blood coagulation and hemostasis - can only come clinically. The more clearly the chemistry of the coagulation mechanism is understood and the more accurate the diagnosis, the better will be the prospect of approaching successfully the problem of hemostasis.

* This work was supported by a grant from the National Heart Institute, National Institutes of Health, U. S. Public Health Service


 

  • References

  • 1 Quick A. J. The Coagulation Defect in Sweet Clover Disease and in the Hemorrhagic Chick Disease in Dietary Origin. A Consideration of the Source of Prothrombin. Amer. J. Physiol 118: 260 1937;
    PubMedGoogle Scholar
  • 2 Seegers W. H. Prothrombin. Harvard Univ. Press; Cambridge, Mass.: 1962
    Google Scholar
  • 3 Macfariane R. G. An Enzyme Cascade in the Blood Clotting Mechanism, and Its Function As a Biochemical Amplifier. Nature (Lond.) 202: 498 1964;
    CrossrefPubMedGoogle Scholar
  • 4 Davie E. W, Ratnoff O. D. Waterfall sequence for instrinsic blood clotting. Science 145: 1310 1964;
    CrossrefPubMedGoogle Scholar
  • 5 Seegers W. H. Review: Basic Enzymology of Blood Coagulation. Thrombos. Diathes. haemorrh. (Stuttg.) 14: 213 1965;
    PubMedGoogle Scholar
  • 6 Quick A. J. The Diagnosis of Common Hereditary Hemorrhagic Diseases. Ann. intern. Med 55: 201 1961;
    CrossrefPubMedGoogle Scholar
  • 7 Quick A. J, Favre-Gilly J. E. Fibrin, A Factor Influencing the Consumption of Prothrombin in Coagulation. Amer. J. Physiol 158: 387 1949;
    PubMedGoogle Scholar
  • 8 Quick A. J. The Normal Antithrombin of the Blood and Its Relation to Heparin. Amer. J. Physiol 123: 112 1938;
    PubMedGoogle Scholar
  • 9 Bettex-Galland M, Lüscher E. F. Extraction of an Actomyosin-like Protein from Human Erythrocytes. Nature (Lond.) 184: 276 1959;
    PubMedGoogle Scholar
  • 10 Quick A. J, Georgatsos J. G, Hussey C. V. The Clotting Activity of Human Erythrocytes: Theoretical and Clinical Implications. Amer. J. med. Sci 228: 207 1954;
    CrossrefPubMedGoogle Scholar
  • 11 Quick A. J. Hemolysate Prothrombin Consumption Time: A New Test for Thrombo-plastinogenic Coagulation Defects. J. Lab. clin. Med 57: 290 1961;
    PubMedGoogle Scholar
  • 12 Quick A. J, Hussey C. V, Epstein E. Activation of Thromboplastinogen by Thrombin. Amer. J. Physiol 174: 123 1953;
    PubMedGoogle Scholar
  • 13 Warner E. D, Brinkhous K. M, Smith H. P. A Quantitative Study of Blood Clotting: Prothrombin Fluctuations Under Experimental Conditions. Amer. J. Physiol 114: 667 1963;
    PubMedGoogle Scholar
  • 14 Ware A. G, Seegers W. H. Two-stage Procedure for the Quantitative Determination of Prothrombin Concentration. Amer. clin. Path 19A: 11 1949;
    PubMedGoogle Scholar
  • 15 Johnson S.A, Caldwell M. J, Monto R. W. The Blood Coagulation Mechanism in Thrombocytopenic Blood. Thrombos. Diathes. haemorrh. (Stuttg.) 1: 433 1957;
    PubMedGoogle Scholar
  • 16 Quick A. J, Hussey C. V. Hereditary Thrombopathie Thrombocytopenia. Amer. J. med. Sci 245: 643 1963;
    PubMedGoogle Scholar
  • 17 Quick A. J, Hussey C. V, Geppert M. Prothrombin: Analytical and Clinical Aspects. Comparison of the One- and Two-stage Methods. Amer. J. med. Sci 246: 517 1963;
    CrossrefPubMedGoogle Scholar
  • 18 Quick A. J. On Various Properties of Thromboplastin (Aqueous Tissue Extracts). Amer. J. Physiol 114: 282 1936;
    PubMedGoogle Scholar
  • 19 Mertz E. T, Seegers W. H, Smith H. P. Prothrombin, Thromboplastin and Thrombin: Quantitative Interrelationship. Proc. Soc. exp. Biol. (N. Y.) 42: 604 1938;
    PubMedGoogle Scholar
  • 20 Alexander B, Goldstein R, Landwehr G. The Prothrombin Conversion Accelerator of Serum (SPCA): Its Partial Purification and Its Properties Compared with Serum Ac-globulin. J. clin. Invest 29: 881 1950;
    CrossrefPubMedGoogle Scholar
  • 21 Quick A. J. The Assay and Properties of Labile Factor (Factor V). J. clin. Path 13: 457 1960;
    CrossrefPubMedGoogle Scholar
  • 22 Friedmann I. A, Quick A. J, Higgins F, Hussey C. V, Hickey M. E. Hereditary Labile Factor (Factor V) Deficiency. J. A. M. A 175: 370 1961;
    CrossrefPubMedGoogle Scholar
  • 23 Quick A. J, Stefanini M. Nature of Action of the Labile Factor in Formation of Thrombin. Amer. J. Physiol 160: 512 1950;
    PubMedGoogle Scholar
  • 24 Quick A. J, Hussey C. V. Hereditary Hypoprothrombinaemias. Lancet I: 173 1962;
    PubMedGoogle Scholar
  • 25 Hougie C, Barrow E. M, Graham J. B. Stuart Clotting Defect. I. Segregation of an Hereditary Hemorrhagic State from the Heterogeneous Group Heretofore Called “Stable Factor” (SPCA, Proconvertin, Factor VII) Deficiency. J. clin. Invest 36: 485 1957;
    CrossrefPubMedGoogle Scholar
  • 26 Telfer T. P, Derisori K. W, Wright D. R. A ‘New’ Coagulation Defect. Brit. J. Haemat 2: 308 1956;
    CrossrefPubMedGoogle Scholar
  • 27 Brinkhous K. M, Smith H. P, Warner E. D. Plasma Prothrombin Level in Normal Infancy and in Hemorrhagic Disease of the Newborn. Amer. J. med. Sci 193: 475 1937;
    CrossrefPubMedGoogle Scholar
  • 28 Quick A. J, Grossmann A. M. Concentration of Prothrombin in Blood of Babies (3 to 7 days old). Proc. Soc. exp. Biol. (N. Y.) 40:647 (1939); Prothrombin Concentration in Newborn. Ibid. 41:221 (1939); The Nature of the Hemorrhagic Diseases of the Newborn. Delayed Restoration of the Prothrombin Level. Amer. J. med. Sci 199: 1 1940;
    PubMedGoogle Scholar
  • 29 Biggs R, Douglas A. S. The Measurement of Prothrombin Plasma. A Case of Prothrombin Deficiency. J. clin. Path 6: 15 1953;
    CrossrefPubMedGoogle Scholar
  • 30 Warner E. D, Brinkhous K. M, Smith H. P. Bleeding Tendency of Obstructive Jaundice: Prothrombin Deficiency and Dietary Factors. Proc. Soc. exp. Biol. (N. Y.) 37: 628 1939;
    PubMedGoogle Scholar
  • 31 Quick A. J. One-stage Prothrombin Time in the Control of Anticoagulant Therapy. Anticoagulant Therapy in Ischemic Heart Disease 381-388 Sterling Nichol E. Editor. Published by Miami Heart Institute; 1965
    Google Scholar
  • 32 Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path 6: 23 1953;
    CrossrefPubMedGoogle Scholar
  • 33 Biggs R, Douglas A.S, Macfarlane R. G, Dacie J. V, Pitney W. R, Merskey C, O’Brien J. R. Christmas Disease, A Condition Previously Mistaken for Haemophilia. Brit. med. J II: 1378 1952;
    PubMedGoogle Scholar
  • 34 Quick A. J, Stefanini M. The State of Component A (Prothrombin) in Human Blood: Evidence That It is Partly Free and Partly in an Inactive or Precursor Form. J. Lab. clin. Med 34: 1203 1949;
    PubMedGoogle Scholar
  • 35 Quick A.J. The Determinant of the Prothrombin Time in Normal Human Plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 2: 226 1958;
    PubMedGoogle Scholar
  • 36 Quick A. J, Hussey C. V. On the Comparative Prothrombin Avtivity of Human and Dog Plasma. J. clin. Invest 30: 903 1951;
    CrossrefPubMedGoogle Scholar